Tag: ventricular assist device market size

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Ventricular Assist Device Market?

The market size for ventricular assist devices has experienced a swift increase in recent years. Projected to expand from $2.12 billion in 2024 to $2.39 billion in 2025, it boasts a compound annual growth rate (CAGR) of 12.6%. This significant growth during the historical period can be linked to the escalating frequency of heart failure cases, alongside an increased demand for organ transplant procedures.

What Growth Rate Is Forecasted for the Ventricular Assist Device Market by 2029?

In the coming years, the ventricular assist device market is anticipated to witness significant growth and expand to a value of $3.91 billion by 2029 with a compound annual growth rate (CAGR) of 13.1%. Several factors have been identified that will contribute to this suggested growth during the forecast period, including a growing demand for destination therapy, an aging global population, increased spending on healthcare, and a heightened understanding and awareness of heart failure treatments. Furthermore, a number of emerging trends are expected to shape the market during this period, such as enhancing the durable lifespan of VADs, downsizing of VADs, advancements in pump technologies, an emphasis on the safety and effectiveness of VADs, efforts to reduce VAD-related complications, and the use of ventricular assist devices inserted through the skin.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6680&type=smp

Which Key Companies Are Shaping the Future of the Ventricular Assist Device Market?

Major companies operating in the ventricular assist device market include Abiomed, Abbott Laboratories, Medtronic, LivaNova PLC, Terumo Corporation, Berlin Heart GmbH, Cirtec, Jarvik Heart Inc., SynCardia Systems LLC., Calon Cardio-Technology Ltd, Huadong Medicine Co. Ltd, Shenzhen Hexin Zondan Medical Equipment Co. Ltd, Sun Medical Technology Research Corp., Boston Scientific Corporation, CorWave SA, CH Biomedical (USA) Inc, Evaheart Inc, BiVACOR Inc, ReliantHeart Inc, Cardiac Assist Inc, Heart Ware International, Braile Biomedica Ltd

Which Factors Are Driving Demand in the Ventricular Assist Device Industry?

The escalation of heart-related conditions is one of the main drivers propelling the growth of the ventricular assist device market. Cardiovascular disorders, which are triggered by elevated blood pressure, smoking, elevated cholesterol levels, lack of physical activity, among other risk factors, have been on the rise. Noncontagious diseases like diabetes, chronic respiratory diseases, and hypertension-induced heart attacks also contribute to the rise of these disorders. As the number of cardiovascular disorders surge, so does the demand for ventricular assist devices, which serve as a lifeline for patients with severe cardiac conditions. The National Library of Medicine, a federal agency based in the United States, stated in October 2022 that by 2035, it is estimated that 45.1% of the American population will suffer from some form of cardiovascular disease. The overall expenses associated with these disorders are predicted to hit $1.1 trillion by 2035. Consequently, the increasing incidence of cardiovascular disorders is poised to spur the demand for ventricular assist devices in the anticipated period.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=6680&type=smp

How Is the Ventricular Assist Device Market Segmented by Several Divisions?

The ventricular assist device market covered in this report is segmented –

1) By Product: Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), Biventricular Assist Devices (BIVADs).

2) By Type: Pulsatile Flow, Continuous Flow

3) By Design: Transcutaneous Ventricular Assist Devices, Implantable Ventricular Assist Devices

4) By Application: Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Bridge-To-Recovery (BTR) Therapy, Bridge-To-Candidacy (BTC) Therapy

5) By End Users: Hospital, Ambulatory Surgical Centres, Cardiology Centres

Subsegments:

1) By Left Ventricular Assist Devices (LVADs): Implantable LVADs, Temporary LVADs

2) By Right Ventricular Assist Devices (RVADs): Implantable RVADs, Temporary RVADs

3) By Biventricular Assist Devices (BIVADs): Full Support BIVADs, Hybrid BIVADs

What are the Emerging Market Trends Driving the Growth of the Ventricular Assist Device Industry?

Ventricular assist devices that are inserted percutaneously are gaining traction in the market. This non-pulsatile axial flow pump, situated across the aortic valve, works by pumping blood from the left ventricle. The use of a percutaneously inserted VAD can effectively reduce the load on the left ventricle, as well as decrease myocardial oxygen consumption. This enhances cardiac output and minimizes left ventricular end-diastolic pressure. For instance, Impella, a percutaneous VAD developed by Abiomed Inc., a medical device company based in the US, was made available for suitable pediatric patients in the USA in August 2022. The device effectively provides adequate cardiac support for patients with a malfunctioned left ventricle. It’s also capable of replacing extracorporeal membrane oxygenation (ECMO) or being used alongside it to enhance hemodynamics.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report

Which Regions Are Driving Growth in the Ventricular Assist Device Market?

North America was the largest region in the ventricular assist device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ventricular assist device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6680

This Report Delivers Insight On:

1. How big is the ventricular assist device market, and how is it changing globally?

2. Who are the major companies in the ventricular assist device market, and how are they performing?

3. What are the key opportunities and risks in the ventricular assist device market right now?

4. Which products or customer segments are growing the most in the ventricular assist device market?

5. What factors are helping or slowing down the growth of the ventricular assist device market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the ventricular assist device industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What Is the Current and Projected Market Size of the Ventricular Assist Device Market Through 2034?

The market size for ventricular assist devices has seen swift expansion in recent times. It is projected to rise from $2.12 billion in 2024 to around $2.39 billion in 2025, reflecting a Compound Annual Growth Rate (CAGR) of 12.6%. This growth during the historical period is fundamentally driven by a surge in heart failure cases and increased need for organ transplant procedures.

The market size for ventricular assist devices is projected to experience swift expansion in the coming years. It’s estimated to reach $3.91 billion by 2029, with a compound annual growth rate (CAGR) of 13.1%. A number of factors can be credited for the anticipated growth during the forecast period including the rising requirement for destination therapy, the aging population, hikes in healthcare spending, and increased awareness about heart failure treatments. Some major trends to watch for during the forecast period involve initiatives to improve VAD longevity, efforts to make VADs smaller, advanced pump technologies, emphasis on the safety and efficiency of VADs, attempts to decrease VAD side effects and the emergence of percutaneously inserted ventricular assist devices.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6680&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Ventricular Assist Device Market?

The escalated occurrence of cardiovascular ailments is a primary stimulant for the expansion of the ventricular assist device market. Such heart conditions arise from factors including elevated blood pressure, smoking, heightened cholesterol levels, a lack of physical activity, among others. In addition, non-infectious diseases like diabetes, chronic respiratory illness, and hypertension-induced heart attacks contribute to the rise in cardiovascular disorders. This surge is likely to amplify the requirement for ventricular assist devices that play an essential role in supporting gravely sick cardiac patients. As reported by the National Library of Medicine, an American federal agency, as of October 2022, it is projected that by 2035, cardiovascular disease will afflict 45.1% of the American populace. Predictions suggest that the total expenditure related to these heart ailments will escalate to $1.1 trillion by 2035. Thus, the mounting occurrence rate of cardiovascular ailments is likely to spur the demand for ventricular assist devices in the future.

Which Key Market Segments Comprise the Ventricular Assist Device Market and Drive Its Revenue Growth?

The ventricular assist device market covered in this report is segmented –

1) By Product: Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), Biventricular Assist Devices (BIVADs).

2) By Type: Pulsatile Flow, Continuous Flow

3) By Design: Transcutaneous Ventricular Assist Devices, Implantable Ventricular Assist Devices

4) By Application: Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Bridge-To-Recovery (BTR) Therapy, Bridge-To-Candidacy (BTC) Therapy

5) By End Users: Hospital, Ambulatory Surgical Centres, Cardiology Centres

Subsegments:

1) By Left Ventricular Assist Devices (LVADs): Implantable LVADs, Temporary LVADs

2) By Right Ventricular Assist Devices (RVADs): Implantable RVADs, Temporary RVADs

3) By Biventricular Assist Devices (BIVADs): Full Support BIVADs, Hybrid BIVADs

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=6680&type=smp

Which Areas Are Leading Regions in the Ventricular Assist Device Market Expansion Across the Globe?

North America was the largest region in the ventricular assist device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ventricular assist device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Key Market Trends in theVentricular Assist Device Market Over the Coming Years?

Ventricular assist devices that are inserted percutaneously are seeing an increased demand within the market. Essentially, they are non-pulsatile axial flow pumps that are positioned across the aortic valve, pumping blood from the left ventricle. The benefits of a percutaneously inserted ventricular assist device (VAD) include decreased pressure on the left ventricle, reduced myocardial oxygen consumption, improved cardiac output, and a reduction in left ventricular end-diastolic pressure. In August 2022, a company based in the US called Abiomed Inc. released Impella, a percutaneous VAD designed for eligible pediatric patients in the US. With the ability to significantly support the cardiac function in patients with a failed left ventricle, the device can function as a replacement for extracorporeal membrane oxygenation (ECMO), or accompany other therapies to enhance hemodynamics.

View the full report here:

https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report

How Is the Ventricular Assist Device Market Conceptually Defined?

A ventricular assist device refers to an implantable mechanical circulatory device used to treat heart failure by pumping blood from the heart to the rest of the body, improving circulation to vital organs. A wide range of ventricular assist devices are approved by the US FDA to provide long-term or permanent support to patients with end-stage heart failure.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6680

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Factors Are Propelling the Market Growth of theVentricular Assist Device Market from 2025 to 2034?

The surge in cardiovascular diseases is propelling the expansion of the ventricular assist device market. These heart conditions are induced by factors such as hypertension, smoking, elevated cholesterol levels, sedentary lifestyles, and others. The rise in cardiovascular diseases can also be attributed to non-infectious ailments like diabetes, chronic pulmonary disease, and hypertension-induced heart attacks. This notable surge in heart conditions is anticipated to enhance the need for ventricular assist devices, which serve as a crucial lifeline for critically ill heart patients. To illustrate, the National Library of Medicine, a federal agency in the US, stated in October 2022 that by 2035, cardiovascular diseases will affect 45.1% of the US populace. The collective cost of these heart-related ailments is expected to escalate to approximately $1.1 trillion by 2035. Hence, the upturn in cardiovascular diseases is anticipated to enhance the need for ventricular assist devices in the speculated time frame.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6680&type=smp

#What is the Anticipated CAGR of theVentricular Assist Device Market, and What Factors Will Drive It?

In recent times, the ventricular assist device market has seen fast-paced growth. Expected to expand from a value of $2.12 billion in 2024, it is predicted to reach $2.39 billion in 2025, charting a compound annual growth rate (CAGR) of 12.6%. The upswing in the historic period can be traced back to an elevation in the incidence of heart failure, coupled with a surge in the need for organ transplantation processes.

In the coming years, the ventricular assist device market is projected to experience a significant upswing. It is forecasted to expand to $3.91 billion by 2029 with a compound annual growth rate (CAGR) of 13.1%. This expansion during the predicted period can be linked to an escalating demand for destination therapy, a growing elderly population, elevated healthcare expenses and increased comprehension about heart failure treatments. Major trends expected to shape this market include improving the lifespan of VADs, reduction in the size of VADs, advancements in pump technologies, greater emphasis on VAD safety and effectiveness, focusing on minimizing the side effects of VADs, along with ventricular assist devices that can be inserted through the skin.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6680

How Are Market Trends and Innovations Revolutionizing theVentricular Assist Device Industry in Recent Times?

The market is witnessing an increased preference for ventricular assist devices inserted percutaneously. These devices are non-pulsatile axial flow pumps, positioned across the aortic valve, facilitating blood pumping from the left ventricle. They help reduce the burden on the left ventricle and myocardial oxygen consumption, which in turn enhances cardiac output while lowering left ventricular end-diastolic pressure. For instance, in August 2022, a US-based medical device organization, Abiomed Inc., unveiled its percutaneous VAD product, Impella, to be used for qualifying pediatric patients in the USA. This device can compensate for a failing left ventricle in patients and replace or accompany extracorporeal membrane oxygenation (ECMO) to better hemodynamics.

Which Key Market Players Are Shaping the Future and Growth of theVentricular Assist Device Market?

Major companies operating in the ventricular assist device market include Abiomed, Abbott Laboratories, Medtronic, LivaNova PLC, Terumo Corporation, Berlin Heart GmbH, Cirtec, Jarvik Heart Inc., SynCardia Systems LLC., Calon Cardio-Technology Ltd, Huadong Medicine Co. Ltd, Shenzhen Hexin Zondan Medical Equipment Co. Ltd, Sun Medical Technology Research Corp., Boston Scientific Corporation, CorWave SA, CH Biomedical (USA) Inc, Evaheart Inc, BiVACOR Inc, ReliantHeart Inc, Cardiac Assist Inc, Heart Ware International, Braile Biomedica Ltd

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report

What Are the Core Segments of the Ventricular Assist Device Market, and How Do They Contribute to Growth?

The ventricular assist device market covered in this report is segmented –

1) By Product: Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), Biventricular Assist Devices (BIVADs).

2) By Type: Pulsatile Flow, Continuous Flow

3) By Design: Transcutaneous Ventricular Assist Devices, Implantable Ventricular Assist Devices

4) By Application: Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Bridge-To-Recovery (BTR) Therapy, Bridge-To-Candidacy (BTC) Therapy

5) By End Users: Hospital, Ambulatory Surgical Centres, Cardiology Centres

Subsegments:

1) By Left Ventricular Assist Devices (LVADs): Implantable LVADs, Temporary LVADs

2) By Right Ventricular Assist Devices (RVADs): Implantable RVADs, Temporary RVADs

3) By Biventricular Assist Devices (BIVADs): Full Support BIVADs, Hybrid BIVADs

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=6680&type=smp

What Regions Are Dominating the Ventricular Assist Device Market Growth?

North America was the largest region in the ventricular assist device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ventricular assist device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Ventricular Assist Device Market 2025, By The Business Research Company:

Dehumidifiers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/dehumidifiers-global-market-report

Humidifying Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/humidifying-equipment-global-market-report

Warm Air Heating Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/warm-air-heating-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What key factors are powering the surge in the ventricular assist device market right now?

The market size for ventricular assist devices has witnessed substantial expansion in the last few years. Projected growth indicates an increase from $2.12 billion in 2024 to $2.39 billion in 2025, with a compound annual growth rate (CAGR) of 12.6%. The reasons for this prior growth trend consist of a higher incidence of heart failure and an escalated demand for procedures involving organ transplantation.

How fast Is the ventricular assist device market expected to grow, and what’s its future value?

The market size of pizza boxes is projected to witness robust expansion in the upcoming years, escalating to $4.37 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 7.9%. The predicted rise during the forecast period is primarily due to the global surge in pizza market, intensity of market competition and differentiation, adherence to health and safety norms, consumer inclination towards eco-friendly packaging, and convenience-oriented packaging. Significant trends for the forecast period encompass design modernizations for functionality, customization and branding, convenience-led packaging, groundbreaking materials and technologies, and market reaction to consumer behavior.

Get your ventricular assist device market report here!

https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report

What are the leading drivers of growth in the ventricular assist device market?

The rise in cases of cardiovascular conditions is propelling the expansion of the ventricular assist device market. Heart diseases, often attributed to factors such as hypertension, smoking, high cholesterol, and lack of physical activity, fall under the umbrella of cardiovascular disorders. The surge in these conditions can also be attributed to non-infectious diseases like diabetes, chronic respiratory diseases, and heart attacks brought about by elevated blood pressure. The notable upsurge in such disorders is set to augment the demand for ventricular assist devices, which serve as an essential support framework for critically ill heart patients. As an example, the US-based National Library of Medicine documented in October 2022 that an estimated 45.1% of the US populace will be affected by cardiovascular disease by 2035. The overall expenses related to cardiovascular diseases are predicted to hit $1.1 trillion in 2035. Consequently, the rise in cardiovascular disorder cases will likely spur the demand for ventricular assist devices in the projected period.

What are the key segments defining the ventricular assist device market?

The ventricular assist device market covered in this report is segmented –

1) By Product: Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), Biventricular Assist Devices (BIVADs).

2) By Type: Pulsatile Flow, Continuous Flow

3) By Design: Transcutaneous Ventricular Assist Devices, Implantable Ventricular Assist Devices

4) By Application: Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Bridge-To-Recovery (BTR) Therapy, Bridge-To-Candidacy (BTC) Therapy

5) By End Users: Hospital, Ambulatory Surgical Centres, Cardiology Centres

Subsegments:

1) By Left Ventricular Assist Devices (LVADs): Implantable LVADs, Temporary LVADs

2) By Right Ventricular Assist Devices (RVADs): Implantable RVADs, Temporary RVADs

3) By Biventricular Assist Devices (BIVADs): Full Support BIVADs, Hybrid BIVADs

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6680&type=smp

Who are the key players steering the development of the ventricular assist device market?

Major companies operating in the ventricular assist device market include Abiomed, Abbott Laboratories, Medtronic, LivaNova PLC, Terumo Corporation, Berlin Heart GmbH, Cirtec, Jarvik Heart Inc., SynCardia Systems LLC., Calon Cardio-Technology Ltd, Huadong Medicine Co. Ltd, Shenzhen Hexin Zondan Medical Equipment Co. Ltd, Sun Medical Technology Research Corp., Boston Scientific Corporation, CorWave SA, CH Biomedical (USA) Inc, Evaheart Inc, BiVACOR Inc, ReliantHeart Inc, Cardiac Assist Inc, Heart Ware International, Braile Biomedica Ltd

What emerging trends are influencing the growth of the ventricular assist device market?

Ventricular assist devices inserted percutaneously are increasingly gaining traction in the market. These non-pulsatile axial flow pumps are fixed over the aortic valve, pumping blood out of the left ventricle. Their percutaneous insertion aids in reducing the load on the left ventricle and the consumption of myocardial oxygen, thereby enhancing cardiac output and lowering left ventricular end-diastolic pressure. For instance, Impella, a percutaneous VAD engineered by the US medical device firm, Abiomed Inc., in August 2022, was launched for suitable pediatric patients in the United States. This device, designed to provide adequate cardiac support, helps compensate for a malfunctioning left ventricle in patients. Furthermore, it can replace extracorporeal membrane oxygenation (ECMO) or be used jointly to enhance hemodynamics.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6680

Which regions are most influential in expanding the ventricular assist device market?

North America was the largest region in the ventricular assist device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ventricular assist device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Virtual Reality Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/virtual-reality-services-global-market-report

Virtual Reality In Healthcare Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/virtual-reality-in-healthcare-global-market-report

Fitness Platforms for Disabled Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/fitness-platforms-for-disabled-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Will the Ventricular Assist Device Market Grow Over the Forecast Period Based on Its Expected CAGR?

The market for ventricular assist devices has seen a surge in size over the past few years. It is projected to expand from $2.12 billion in 2024 to $2.39 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 12.6%. The past expansion can be ascribed to a rising occurrence of heart failure and an increased necessity for organ transplantation procedures.

Expectations are high for substantial expansion in the ventricular assist device market in the coming years. By 2029, it is projected to have grown to a sizable $3.91 billion, with a compound annual growth rate (CAGR) of 13.1%. This predicted growth is largely due to factors such as the growing demand for destination therapy, an aging demographic, increased health budget allocations, and heightened awareness regarding heart failure treatments. In the years ahead, we can expect several trends, including enhancement of VAD longevity, miniaturization of VADs, progressive pump technologies, an amplified focus on safety and efficiency of VAd, an emphasis on minimizing VAD-related side effects, and the development of ventricular assist devices inserted percutaneously.

Which Factors Are Enhancing the Growth of the ventricular assist device Market?

The surge in cardiovascular ailments is fueling the growth of the ventricular assist device market. Heart diseases, which are the upshot of high blood pressure, smoking, elevated cholesterol, sedentary lifestyle, and other elements, are known as cardiovascular disorders. Noncommunicable afflictions such as diabetes, chronic respiratory illness, and heart attacks caused by hypertension have also contributed to the rise in cardiovascular disorders. The marked rise in these disorders is projected to increase the need for ventricular assist devices, which serve as a crucial lifeline for critically sick heart patients. In October 2022, the National Library of Medicine, an American federal agency, predicted that by 2035, 45.1% of the American population will suffer from cardiovascular disease. The complete expenditure on cardiovascular illnesses is forecasted to reach $1.1 trillion in 2035. Consequently, the surge in the incidence of cardiovascular diseases is expected to fuel the demand for ventricular assist devices during the anticipated period.

Explore Comprehensive Insights Into The Global Ventricular Assist Device Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6680&type=smp

Who Are the Dominant Players Expanding Their Reach in the Ventricular Assist Device Market?

Major companies operating in the ventricular assist device market include:

• Abiomed_x000D_

• Abbott Laboratories_x000D_

• Medtronic_x000D_

• LivaNova PLC_x000D_

• Terumo Corporation_x000D_

What Are the Top Trends Shaping the Evolution of the Ventricular Assist Device Market?

Ventricular assist devices that are inserted percutaneously are enjoying an increased preference in the marketplace. These devices, which are non-pulsatile axial flow pumps, are placed over the aortic valve and pump blood away from the left ventricle of the heart. By reducing the pressure on the left ventricle and decreasing myocardial oxygen consumption, a percutaneously inserted VAD enhances cardiac output and curbs the end-diastolic pressure in the left ventricle. For instance, in August 2022, Abiomed Inc., a medical device firm based in the U.S, launched Impella, a percutaneous VAD suitable for qualifying pediatric patients within the USA. This device offers adequate cardiac support for patients experiencing left ventricle failure. It can either replace extracorporeal membrane oxygenation (ECMO) or work alongside other treatments to better the patient’s hemodynamics.

Secure Your Global Ventricular Assist Device Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report

Which Segments of the Ventricular Assist Device Market Hold the Most Potential for Future Development?

The ventricular assist device market covered in this report is segmented –

1) By Product: Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), Biventricular Assist Devices (BIVADs).

2) By Type: Pulsatile Flow, Continuous Flow

3) By Design: Transcutaneous Ventricular Assist Devices, Implantable Ventricular Assist Devices

4) By Application: Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Bridge-To-Recovery (BTR) Therapy, Bridge-To-Candidacy (BTC) Therapy

5) By End Users: Hospital, Ambulatory Surgical Centres, Cardiology Centres

Subsegments:

1) By Left Ventricular Assist Devices (LVADs): Implantable LVADs, Temporary LVADs

2) By Right Ventricular Assist Devices (RVADs): Implantable RVADs, Temporary RVADs

3) By Biventricular Assist Devices (BIVADs): Full Support BIVADs, Hybrid BIVADs

Which Regions Are Setting the Pace for Ventricular Assist Device Market Growth?

North America was the largest region in the ventricular assist device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ventricular assist device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Is the Ventricular Assist Device Market Defined Across Different Regions?

A ventricular assist device refers to an implantable mechanical circulatory device used to treat heart failure by pumping blood from the heart to the rest of the body, improving circulation to vital organs. A wide range of ventricular assist devices are approved by the US FDA to provide long-term or permanent support to patients with end-stage heart failure.

Browse Through More Similar Reports By The Business Research Company:

Virtual Reality Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/virtual-reality-services-global-market-report

Virtual Reality In Healthcare Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/virtual-reality-in-healthcare-global-market-report

Fitness Platforms for Disabled Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/fitness-platforms-for-disabled-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: